Literature DB >> 27408396

Thymoma with Concomitant Pure Red Cell Aplasia, Good's Syndrome and Myasthenia Gravis Responding to Rituximab.

Ahmad I Antar1, Zaher K Otrock2, Mohamed A Kharfan-Dabaja3, Rami A Mahfouz4, Raafat S Alameddine1, Nadim M W El-Majzoub4, Ziad M Salem1.   

Abstract

Thymomas are often associated with a variety of autoimmune diseases, mostly myasthenia gravis. The association of thymomas with both pure red cell aplasia (PRCA) and Good's syndrome is exceedingly rare. To the best of our knowledge, the combination of a thymoma with manifestations of myasthenia gravis, PRCA, and Good's syndrome, as in our case herein, has not been described before in the medical literature. We present a 90-year-old man initially diagnosed with an asymptomatic thymoma. Later, he developed generalized muscle weakness and was found to have severe anemia. He was diagnosed with PRCA, myasthenia gravis and Good's syndrome. He responded to rituximab with restoration of bone marrow erythroid maturation and stabilization of red blood cell counts.

Entities:  

Keywords:  Good’s syndrome; Myasthenia gravis; Pure red cell aplasia; Response; Rituximab; Thymoma

Year:  2014        PMID: 27408396      PMCID: PMC4925473          DOI: 10.1007/s12288-014-0478-x

Source DB:  PubMed          Journal:  Indian J Hematol Blood Transfus        ISSN: 0971-4502            Impact factor:   0.900


  16 in total

1.  Thymomas alter the T-cell subset composition in the blood: a potential mechanism for thymoma-associated autoimmune disease.

Authors:  V Hoffacker; A Schultz; J J Tiesinga; R Gold; B Schalke; W Nix; R Kiefer; H K Müller-Hermelink; A Marx
Journal:  Blood       Date:  2000-12-01       Impact factor: 22.113

2.  Anti-CD20 monoclonal antibody rituximab for the treatment of B-cell chronic lymphocytic leukemia-associated pure red cell aplasia.

Authors:  Despina Pantelidou; Costas Tsatalas; Dimitris Margaritis; Vasiliki Kaloutsi; Emmanuel Spanoudakis; George Bourikas
Journal:  Hematol J       Date:  2004

3.  Pure red cell aplasia associated with thymoma: clinical insights from a 50-year single-institution experience.

Authors:  Carrie A Thompson; David P Steensma
Journal:  Br J Haematol       Date:  2006-11       Impact factor: 6.998

4.  Thymoma with paraneoplastic syndromes, Good's syndrome, and pure red cell aplasia.

Authors:  Jacolien van der Marel; Paul V M Pahlplatz; Willem-Hans Steup; Eduard R Hendriks
Journal:  J Thorac Oncol       Date:  2007-04       Impact factor: 15.609

5.  Cyclosporine A used as a single drug in the treatment of pure red cell aplasia associated with thymoma.

Authors:  J A Garcia Vela; M C Monteserin; F Oña; L M Barea; A Lastra; V Pérez
Journal:  Am J Hematol       Date:  1993-02       Impact factor: 10.047

Review 6.  Thymoma and autoimmunity.

Authors:  Shahar Shelly; Nancy Agmon-Levin; Arie Altman; Yehuda Shoenfeld
Journal:  Cell Mol Immunol       Date:  2011-02-14       Impact factor: 11.530

Review 7.  Thymoma.

Authors:  H K Müller-Hermelink; A Marx
Journal:  Curr Opin Oncol       Date:  2000-09       Impact factor: 3.645

8.  Thymoma with pure red cell aplasia and Good's syndrome.

Authors:  Jun Chen; Yongbo Yang; Daxing Zhu; Gang Chen; Sen Wei; Xiaoming Qiu; Qinghua Zhou
Journal:  Ann Thorac Surg       Date:  2011-05       Impact factor: 4.330

9.  The role of thymectomy in red cell aplasia.

Authors:  J V Zeok; E P Todd; M Dillon; P DeSimone; J R Utley
Journal:  Ann Thorac Surg       Date:  1979-09       Impact factor: 4.330

10.  Pure red cell aplasia and hypogammaglobulinemia in a patient with thymoma.

Authors:  Chen-Sung Lin; Yuan-Bin Yu; Han-Shui Hsu; Teh-Ying Chou; Wen-Hu Hsu; Biing-Shiun Huang
Journal:  J Chin Med Assoc       Date:  2009-01       Impact factor: 2.743

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.